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Abstract
Background: Myosin Va is a motor protein involved in vesicular transport and its absence leads to movement disorders in
humans (Griscelli and Elejalde syndromes) and rodents (e.g. dilute lethal phenotype in mice). We examined the role of
myosin Va in the postsynaptic plasticity of the vertebrate neuromuscular junction (NMJ).
Methodology/Principal Findings: Dilute lethal mice showed a good correlation between the propensity for seizures, and
fragmentation and size reduction of NMJs. In an aneural C2C12 myoblast cell culture, expression of a dominant-negative
fragment of myosin Va led to the accumulation of punctate structures containing the NMJ marker protein, rapsyn-GFP, in
perinuclear clusters. In mouse hindlimb muscle, endogenous myosin Va co-precipitated with surface-exposed or
internalised acetylcholine receptors and was markedly enriched in close proximity to the NMJ upon immunofluorescence. In
vivo microscopy of exogenous full length myosin Va as well as a cargo-binding fragment of myosin Va showed localisation
to the NMJ in wildtype mouse muscles. Furthermore, local interference with myosin Va function in live wildtype mouse
muscles led to fragmentation and size reduction of NMJs, exclusion of rapsyn-GFP from NMJs, reduced persistence of
acetylcholine receptors in NMJs and an increased amount of punctate structures bearing internalised NMJ proteins.
Conclusions/Significance: In summary, our data show a crucial role of myosin Va for the plasticity of live vertebrate
neuromuscular junctions and suggest its involvement in the recycling of internalised acetylcholine receptors back to the
postsynaptic membrane.
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Introduction
Vertebrate neuromuscular junctions (NMJs) are the synapses
between motoneurones and skeletal muscle fibres and mediate any
kind of voluntary movement [for review, 1,2]. The postsynaptic
face of NMJs is rich in nicotinic acetylcholine receptors (AChRs)
and other specific proteins, such as the AChR clustering factor
rapsyn [3–5]. NMJs form during embryogenesis and are
maintained after a perinatal period of synapse rearrangements
[6,7] in an essentially stable manner for long time periods [8,9],
presumably for the entire life span of a muscle fibre. Despite this
long persistence of the overall structure, individual NMJ
components such as AChRs have much shorter life spans, usually
in the range of days [10]. The analysis of AChR degradation led to
the identification of two metabolically distinct AChR populations
[11,12], so-called junctional (or endplate) and extrajunctional
AChRs. While junctional AChRs were found to have a halflife of
about 10 days, extrajunctional AChRs appear to decrease in
number in the first two postnatal weeks and to exhibit a halflife of
only about 1 day [13]. Also, the structural and functional
properties of AChRs change during early postnatal development,
since embryonic-type AChRs with an alpha(2)-beta-gamma-delta
subunit composition are replaced by adult AChRs consisting of
alpha(2)-beta-epsilon-delta subunits [14]. How and whether the
differences in function and molecular composition of AChRs could
be related to AChR degradation is not well understood. However,
factors that are known to affect AChR stability are innervation and
muscle activity [15–17].
In Torpedo electrocytes, AChRs were shown to be co-
transported with rapsyn in vesicular carriers [18], and in
heterologous tissue culture cells, a rapsyn-GFP fusion protein
was found to travel along the cytoskeleton from the Golgi
apparatus towards the cell surface [19,20]. Given the large
discrepancy between the lifetimes of NMJs and AChRs, there is
need for a regulated turnover of NMJ components, which is
thought to be mediated by their exocytic delivery and endocytic
elimination [2]. A third recycling pool of previously surface-
exposed receptors is apparently available for rapid recruitment
upon NMJ activity-dependent demand [21,22].
In search for the molecular machinery driving such vesicular
transport, we looked for locomotion disorders involving vesicular
transport proteins. Human Elejalde syndrome and Griscelli
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opisthotonus phenotypes [26,27] are characterised by hypomelano-
sis, severe seizures, opisthotonus and premature death and are due
to a lack of functional myosin Va. The molecular motor protein
myosin Va is a processive [28], unconventional myosin with a
broad tissue expression pattern [29] and is known to be involved in
the transport of many vesicular carriers including skin pigment
granules [30–32], neuronal [33,34] and neuroendocrine vesicles
[35]. In skin, myosin Va was shown to be important for capturing
pigment granules in the peripheral F-actin-rich cortex in the
dendritic tips of melanocytes [32]. In the absence of functional
myosin Va, such as upon expression of a dominant-negative
version of the motor (MCLT) or in melanocytes from dilute lethal
mice, pigment granules were not captured in the cell cortex, but
accumulated at the site of highest microtubule density, i.e. in the
perinuclear region [30,32].
In the present study we addressed the question of whether
myosin Va is involved in maintenance and integrity of the
postsynaptic apparatus of the NMJ. We show clear in vivo and in
vitro evidence that myosin Va is in fact essential for long-term
homeostasis of the mouse NMJ and that it may be particularly
important for the recycling of AChR- and rapsyn-containing
vesicles.
Results
DLS/LeJ mice exhibit severe postnatal degeneration of
NMJs
First, we addressed the question whether the absence of
functional myosin Va affects the integrity of NMJs. Therefore,
we took advantage of the DLS/LeJ mouse line which carries the
recessive dilute lethal Myo5a
d-l allele (homozygous leading to light fur
colour, severe convulsions and death within three weeks after
birth). In our experiments, we compared homozygous Myo5a and
heterozygous Myo5a/Myo5a
d-l (both exhibiting black fur colour and
referred to as ‘healthy’, Fig. 1A, at postnatal day 14, P14) with
homozygous Myo5a
d-l siblings (light fur colour, referred to as
‘dilute’, Fig. 1B, at P14) first with respect to aetiopathology during
the first three postnatal weeks. Barring fur colour, no differences
could be observed between healthy and dilute animals until the
ninth postnatal day (P9). Body weights (not shown) and motility
were similar in all littermates (Fig. 1C, Fig. S1A and B, Movie S1)
and convulsions were practically absent (Fig. 1D and Fig. S1C).
However, from P10 onwards, dilute animals ceased growing (not
shown) and did not increase their voluntary movement activities as
it was observed throughout for healthy littermates (Fig. 1C). In
fact, most of the translocation of the dilute animals (Fig. 1C and
Fig. S1A and B) was from now on due to increasingly severe and
prolonged seizures (Fig. S1D and Movies S2 and S3). While
initially (between P10 and P16) mainly the extremities’ muscula-
ture seemed to be affected by spasms, at later time points (P17
through P21) the animals were seen to contract as a whole, round
up and fall on their back, with extended extremities exhibiting
spastic tremor. This was all in sharp contrast to healthy littermates
which continued growing, increased their activity range (Fig. 1C,
Fig. S1A and B, Movies S1, S2, S3) and behaved normally.
To investigate whether such externally visible aetiopathology
would show an internal correlate in the synapses regulating muscle
contraction, we extracted different hind limb muscles (tibalis
anterior [TA], gastrocnemius [G], soleus [S] and peronaeus) from
healthy and dilute siblings on P7, P14 or P20. Some of these
muscles were sliced longitudinally and then stained with a
fluorescent marker for AChRs, alpha-bungarotoxin (BGT) cou-
pled to AlexaFluor (AF) 647 (BGT-AF647). Subsequently, we
performed morphometric analysis of NMJs upon maximum z-
projections of 3D stacks obtained with confocal microscopy as
shown in Fig. 1E and F (gastrocnemius samples are depicted).
Interestingly, while at P7 NMJs in healthy and dilute animals were
quite similar in shape (simple plaques; Fig. 1E and F, left panels)
and size (Fig. 1G), at P14 dilute NMJs were about 20% smaller
than in the control (Fig. 1G) and apparently stopped their
morphological maturation, which in wildtype muscles led to
fenestration and arborisation of the NMJ structure (compare
Fig. 1E and F, middle panels). The deterioration of dilute NMJs
was yet more aggravated at P20: NMJs were often fragmented
(Fig. 1F, right panel, Table 1) and their areas were further
diminished (Fig. 1G). In summary, the aetiopathology of seizures
appeared to correlate with the time course of morphological
changes at the NMJ, suggesting that myosin Va might play a role
in the maintenance and/or development of the NMJ.
To rule out, that NMJ sizes simply followed a decrease in
fibre diameter, we measured the latter characteristic for some
muscles at P14 and P20. At P14, when NMJs of dilute muscles
were already more than 20% smaller than the healthy ones,
fibre diameters of TA muscles of healthy and dilute mice were
identical with 23.0 mm60.5 mm( m e a n 6s.e.m., n=45 fields,
521 fibres measured) and 23.0 mm60.3 mm( m e a n 6s.e.m.,
n=46 fields, 502 fibres measured), respectively. Conversely, at
P20 dilute TA muscles exhibited a significantly smaller mean
fibre diameter (21.4 mm62.4 mm, mean6s.e.m., n=6 fields,
138 fibres measured) than their healthy counterparts
(26.1 mm62.4 mm, mean6s.e.m., n=12 fields, 195 fibres
measured). These results clearly show that the shrinkage of
NMJ areas in the absence of functional myosin Va occurs before
and independently of the decrease in fibre diameter. Next, we
tested whether shrinkage and fragmentation observed at the
postsynaptic side were due to a lack of innervation. Therefore,
we studied the innervation status by immunolabelling the
presynaptic proteins, synaptophysin and neurofilament M, in
muscles from dilute and healthy littermates at P20. The
synaptophysin signals nicely matched the AChR signals in
healthy mice (Fig. 1H–H0)a sw e l la sdilute mice (Fig. 1I–I0).
Importantly, each postsynaptic AChR cluster clearly was at
close range to presynaptic synaptophysin, and each endplate
was contacted by a single nerve ending as evidenced by
neurofilament M staining (Fig. 1J–K0). It should be noted, that
the morphological alterations of the postsynapses in dilute mice
(Fig. 1I and K) were mirrored onto the presynapses (Fig. 1I9 and
K9), leading to a clearly different morphology of the nerve
branches when compared to healthy synapses. In particular, the
neurofilament staining in dilute muscles did in most cases not
embrace the synaptic contacts as nicely as in healthy mice, but
rather continued linearly into the elongated postsynaptic area
(Fig. 1K–K0). To verify whether the presynaptic markers were
present in comparable amounts in healthy and dilute muscles, we
undertook a statistical analysis of the BGT-stained areas covered
by either synaptophysin or neurofilament M staining (Table 2).
This revealed that both marker proteins covered about 60% of
the postsynaptic area in wildtype as well as in dilute muscles. To
make sure that these synapses were still capable of nerve
transmission, we elicited hind limb muscle contraction through
sciatic nerve electrodes in live anaesthetised mice at P14. Under
these conditions the stimulated muscles of all healthy and dilute
animals clearly contracted (not shown). Altogether, these data
indicate that dilute muscles are innervated and that synapses are
s t i l la b l et oi n d u c em u s c l ec o n t r a c t i o n ,s u g g e s t i n gt h a tt h e
altered postsynaptic morphology in these mice was not due to
missing innervation.
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PLoS ONE | www.plosone.org 2 December 2008 | Volume 3 | Issue 12 | e3871Figure 1. Aetiopathology and morphological deterioration of NMJs are temporally correlated in DLS/LeJ mice. A–D: Motility
behaviour of healthy and dilute littermates was monitored from P9 to P19 using video analysis. A–B: Habitus of healthy and dilute littermates
(indicated), at P14. Note light fur colour and convulsions in B. C: Quantification of unrestrained movement activity of healthy and dilute animals in a
cage at the indicated ages. Columns, mean activity6s.e.m. (n=6 and n=3 healthy and dilute mice, respectively, from 3 different litters). D:
Quantification of the fraction of observation time during which dilute animals showed clear signs of seizure at the indicated ages. Columns,
mean6s.e.m. (P9, n=5, P13, n=4; P15, n=5; P17, n=3; P19, n=3 mice from at least 3 different litters). E–K0: Tibialis anterior (TA), gastrocnemius (G),
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in the perinuclear region of FLAG-MCLT transfected
myotubes
To further support the hypothesis that myosin Va is important
for the transport of NMJ components in the absence of neuronal
and glial tissues, we next used the C2C12 cell model system.
C2C12 myoblasts were co-transfected with the NMJ marker
protein, rapsyn-GFP, and FLAG or FLAG-MCLT. FLAG-MCLT
is a FLAG-tagged form of MCLT (myosin Va C-terminal long tail)
and was previously shown to act as dominant negative fragment of
myosin Va in different cellular models [32,36]. Its expression in
C2C12 cells was verified by Western blot (Fig. 2A). Transfected
cells were differentiated into myotubes for seven days, fixed,
immunostained for the cis-Golgi marker, GM130, and then
visualised using confocal microscopy. As shown in Fig. 2B–D,
rapsyn-GFP was localised in punctate structures distributed evenly
all over the myotubes in the absence of FLAG-MCLT.
Conversely, in FLAG-MCLT transfected myotubes, rapsyn-GFP
Table 1. NMJ fragmentation in DLS/LeJ mice.
P7 dilute P7 healthy P14 dilute P14 healthy P20 dilute P20 healthy
Mean number of NMJ fragments per NMJ 1,0660,02 1,0360,02 1,1560,05 1,0260,01 2,5260,13 1,1160,04
Minimal number of fragments 1 1 1 1 1 1
Maximal number of fragments 3 2 5 2 7 3
Gastrocnemius muscles of healthy and dilute mice were explanted at P7, P14 or P20. Muscles were fixed, sliced and stained with BGT-AF647. Upon confocal imaging and
image processing, the numbers of NMJ fragments identified as discontinuous gutters of each NMJ were counted. Data, mean6s.e.m. (n.100 analysed NMJs per
condition from at least two different animals).
doi:10.1371/journal.pone.0003871.t001
Table 2. Coverage of BGT-positive area by presynaptic
markers in healthy and dilute muscles.
marker healthy dilute
synaptophysin 66.365.1 (4) 63.461.6 (3)
neurofilament M 59.063.5 (8) 60.764.4 (8)
Peronaeus muscles of healthy and dilute mice were explanted at P19. Muscles
were fixed, sliced and co-stained with postsynaptic BGT-AF647 and antibodies
against presynaptic synaptophysin or neurofilament M. Upon confocal
microscopy and preparation of maximum z-projections, co-localisation between
post- and presynaptic markers was determined. Data show the average fraction
of the BGT-AF647-positive area in individual NMJs, which was covered by
synaptophysin or neurofilament M immunofluorescence signals in percent
6s.e.m. (n-values, number of analysed microscopic fields). The number of
analysed NMJs was .40 from at least two different muscles for each condition.
doi:10.1371/journal.pone.0003871.t002
soleus (S) and peronaeus muscles were taken from healthy and dilute littermates on P7, P14 or P20, sliced longitudinally and stained with BGT-AF647
(E–G) or co-stained with BGT-AF647 and antibodies against synaptophysin or neurofilament M (H–K0). E–F: Maximum z-projections of confocal
images of BGT-AF647 fluorescence signals. Scale bars, 50 mm. G: Quantification of NMJ areas. Graph, average reduction of NMJ sizes in TA, G and S
muscles in dilute as compared to healthy (set to 100%) littermates. Columns, mean6s.e.m. (P7, n=6; P14, n=10 for TA, n=5 for G; P20, n=4; all n-
values, number of animals). H–K0: Maximum z-projections of confocal images from P20 peronaeus muscles showing signals of BGT-AF647 (H–K),
synaptophysin (H9,I 9), neurofilament M (J9,K 9) or the overlay of BGT-AF647 and immunostaining (red and green, respectively; H0–K0). Co-localising
signals in H0–K0, yellow. Scale bar in K0,5 0mm.
doi:10.1371/journal.pone.0003871.g001
Figure 2. Rapsyn-GFP accumulates in the perinuclear regions of FLAG-MCLT expressing C2C12 myotubes. C2C12 myoblast cells were
co-transfected with rapsyn-GFP and FLAG (FLAG) or FLAG-MCLT (FLAG-MCLT). Upon seven days of differentiation, cells were lysed (A) or fixed and
immunostained for GM130 (B–H). A: Bands, western blot signals upon incubation with FLAG or alpha-actinin antibodies of lysates of cells transfected
with FLAG or FLAG-MCLT (indicated). B, E: Optical sections of rapsyn-GFP (green) and GM130 (red). C, F: Maximum z-projections of the cells depicted
in B and E. D, G: Binarised rapsyn-GFP signals from projections shown in C and F for quantification of rapsyn-GFP positive areas. Scale bar, 10 mm. H:
Quantification of total rapsyn-GFP positive area per myotube on binarised maximum z-projections. Data, mean6s.e.m. (n=5 experiments).
doi:10.1371/journal.pone.0003871.g002
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mostly concentrated in perinuclear clusters (Fig. 2E–G, the relative
orientation between GM130 and nuclei is depicted in Fig. S2). It is
unlikely that the effects on amount and localisation of rapsyn-GFP
positive structures observed in FLAG-MCLT co-transfected
myotubes were due to general morphological alterations, since
both FLAG and FLAG-MCLT co-transfected myotubes showed
the typical pearl chain arrays of ring-like Golgi apparatuses
(compare Fig. 2B–C and E–F). These data suggest that myosin Va
has an impact on the distribution of carriers containing NMJ
components.
Myosin Va co-precipitates with surface-exposed or
internalised AChRs
Next we addressed the presence and localisation of endogenous
myosin Va in mouse muscle. Therefore, we first performed affinity
co-precipitation assays, in which we aimed to pull down different
AChR populations. In one approach, we used intraperitoneal (i.p.)
injection of BGT-biotin into live mice. Since BGT is cell-
impermeant, we expected to label by this means only surface-
exposed and internalised (endocytosed and recycling) AChRs. In
another experimental set, we added BGT-biotin to whole muscle
lysates of untreated mice to label the total population of AChRs
[37]. Subsequently, using NeutrAvidin resin, BGT-biotin-labeled
AChRs in all these samples were harvested by affinity precipitation
(AP) and co-precipitating proteins were detected by Western blot
analysis. AChR alpha-subunit precipitated only in the presence
but not the absence of BGT-biotin (Fig. 3A, compare rows 1–2
and 3), showing that AChRs did not bind unspecifically to the
resin. Furthermore, two proteins known to not be associated with
AChRs, namely beta1-adrenergic receptor and calreticulin, could
not be found in the precipitates even in the presence of BGT-
biotin (Fig. 3A, rows 4–5), indicating again the specificity of the
pull-down assay. Using myosin Va antibody, we found strong
signals in brain lysates and precipitates from muscle samples where
BGT-biotin was i.p. injected, but no or barely visible signals were
present in muscle lysates (Fig. 3A, row 6). A similar enrichment of
myosin Va in AChR precipitates was detected also in other
muscles, such as in triceps muscle (Fig. 3A, row 9). Interestingly,
the accumulation of myosin Va was only observed in muscle
samples where BGT-biotin was i.p. injected (Fig. 3A, rows 6 and
9), but not when BGT-biotin was added to the whole muscle lysate
(Fig. 3A, row 7). This suggests, that myosin Va is mostly associated
with either surface-exposed or internalised AChRs, but hardly
with newly synthesised AChRs transported from the endoplasmic
reticulum to the NMJ.
Myosin Va is enriched in the vicinity of the NMJ
To study the localisation of endogenous myosin Va in skeletal
muscle, we performed immunofluorescence stainings. Muscles
from young wildtype mice were briefly fixed, labeled with
antibodies for myosin Va (LF-18 or ham5) and BGT-AF647 for
AChRs and then analysed with confocal microscopy. As depicted
in Fig. 3B for a triceps muscle stained with LF-18 antibody,
myosin Va signals were detected in most fibres as small punctate
structures and as larger aggregates in close proximity to the NMJ.
Movie S4 shows a three-dimensional view of peronaeus muscle
stained with ham5 antibody and BGT-AF647. Controls processed
without primary antibody did not show any sign of punctate or
aggregated signals using the same microscope settings (not shown).
To further confirm the association of myosin Va with structures
bearing NMJ components, we transfected full length myosin Va
fused to GFP into TA muscles of adult wildtype mice employing in
vivo muscle transfection and in situ confocal microscopy essentially
as described previously [38–40]. Ten days after transfection, BGT-
AF647 was locally injected into muscles and then myosin Va-GFP
and BGT-AF647 were simultaneously monitored by in vivo
confocal microscopy. Fig. 3C shows a single layer and a
corresponding maximum z-projection of a 3D stack encompassing
the entire extension of a representative NMJ. The myosin Va-GFP
fluorescence signals were detected in small, punctate structures
closely localised to the NMJ, whereas outside the perijunctional
area the GFP-staining appeared diffuse.
Myosin Va tail co-localises with NMJ marker proteins in
punctate structures
Next, we tested the localisation of a short C-terminal fragment
of myosin Va fused to YFP upon co-expression with rapsyn-GFP
and injection of BGT-AF647 in adult wildtype muscle using in vivo
confocal microscopy as before. Fusion constructs of MCST and
fluorescent proteins have been previously shown to bind to cargo
vesicles which were also transported by endogenous full-length
myosin Va [32]. Fig. 4A shows the maximum z-projection of a 3D
stack encompassing the entire extension of the depicted NMJs. In
the presence of MCST-YFP, NMJs exhibited a rather normal,
unfragmented appearance and rapsyn-GFP perfectly co-localised
with BGT-AF647 signals (Fig. 4A). Notably, the localisation of
MCST-YFP was again quite similar to that of endogenous myosin
Va, i.e. it was found to be enriched in many punctate structures
and aggregates of variable size in the immediate vicinity of NMJs
(Fig. 4A). Having found that the MCST-YFP distribution
mimicked that of endogenous myosin Va, we next asked whether
individual MCST-YFP-positive punctate structures contained also
AChRs and/or rapsyn-GFP. Upon BGT-AF647 injection we took
in vivo confocal images using enhanced detector gains and observed
muscle fibres expressing MCST-YFP and rapsyn-GFP at appar-
ently similar levels. Special care was taken to avoid any signal
crosstalk. As depicted in Fig. 4B–C, most MCST-YFP positive
puncta were either double-positive for rapsyn-GFP (Fig. 4C, blue
arrowheads) or triple-positive for rapsyn-GFP and BGT-AF647
(Fig. 4C, white arrowheads). A quantitative analysis of image
stacks from three different animals revealed that on average
76.3%62.5% (mean6s.e.m.; 956 punctate structures from n=5
image stacks were analysed) of MCST-YFP positive puncta also
contained rapsyn-GFP and BGT-AF647. In the same data sets
9.2%63.6% or 8.5%61.0% of MCST-YFP positive puncta
displayed only either rapsyn-GFP or BGT-AF647 fluorescence,
respectively (all values, mean6s.e.m.). Together with the affinity
precipitation (Fig. 3A) and myosin Va immunofluorescence results
(Fig. 3B and Movie S4), the full length myosin Va-GFP (Fig. 3C)
and MCST-YFP in vivo localisation data (Fig. 4) strongly indicate
that myosin Va is enriched in the region of the NMJ and suggest
that the motor protein interacts directly or indirectly with the
AChR.
The sizes of NMJs are reduced upon inhibition of myosin
Va function
Next we tested the effect of functional ablation of myosin Va on
the size of the NMJ. To that end, TA muscles of adult wildtype
mice were co-transfected with a cytoplasmic YFP probe (to
measure the fibre diameter) and either FLAG-MCLT or a
construct encoding siRNA against myosin Va (silMyoVa). The
latter was shown in neuroendocrine PC12 cells to significantly
reduce myosin Va levels and to lead to blockage of myosin Va
functions as through the action of FLAG-MCLT (Ko ¨gel et al.,
unpublished). As controls, TA muscles were co-transfected with a
cytoplasmic YFP probe and FLAG, or a scrambled siRNA
MyoVa in the Live Mouse NMJ
PLoS ONE | www.plosone.org 5 December 2008 | Volume 3 | Issue 12 | e3871construct. Ten days later, muscles were injected with BGT-AF647
and then visualised using in vivo confocal microscopy. Maximum z-
projections of background-subtracted optical slices showing BGT-
AF647 signals (Fig. 5A and E) were prepared and the sizes of
NMJs determined. The fibre diameter corresponding to any
measured NMJ was taken at the widest extension of the fibre in the
cytoplasmic YFP images (Fig. 5B and F). The distributions of fibre
diameters and NMJ sizes are shown in the histograms of Fig. 5C
and G and Fig. 5D and H, respectively. Comparing the controls
with the animals transfected with either FLAG-MCLT or
silMyoVa, there was no significant difference with regard to fibre
diameter (Fig. 5C and G). Under all conditions, the diameters
Figure 3. Myosin Va is enriched in punctate structures in the postsynaptic region of skeletal muscle. A: Wildtype mice were
intraperitoneally injected with BGT-biotin (BGT, i.p.) or left untreated. Then, lysates of brain as well as TA and triceps muscles (indicated) were
prepared. Samples from untreated mice were incubated in the presence or absence of BGT-biotin (BGT, + or 2, respectively). Then, all samples were
incubated with NeutrAvidin beads and AChRs affinity precipitated. Bands, representative Western blot signals from lysates and affinity precipitates
(AP) using antibodies against proteins as indicated (WB). B: Triceps muscles of wildtype mice (P20) were co-stained with BGT-AF647 and LF-18 myosin
Va antibody and then imaged with confocal microscopy. Single confocal layer and corresponding maximum z-projection of 43 background-
subtracted optical slices taken at 0.7 mm interslice distance encompassing the entire extension of the shown NMJ in depth. Overlay, BGT-AF647 (red),
myosin Va antibody signal (green). Scale bar, 50 mm. C: TA muscles of adult wildtype mice were transfected with full length brain myosin Va-GFP
(BRMyoVa-GFP). Ten days later, transfected muscles were locally injected with BGT-AF647 and then imaged with in vivo confocal microscopy. Single
layer and corresponding maximum z-projection of 29 optical slices taken at 0.7 mm interslice distance encompassing the entire extension of the
shown NMJ in depth. Overlay, BGT-AF647 (red), myosin Va-GFP (green). Scale bar, 50 mm.
doi:10.1371/journal.pone.0003871.g003
MyoVa in the Live Mouse NMJ
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peak at 40 mm. Conversely, NMJ areas exhibited very different
distributions in controls and myosin Va impeding conditions
(Fig. 5D and H). While in the controls NMJ sizes showed a roughly
bell-shaped distribution with a peak at 800 mm
2, NMJ areas were
much smaller in the presence of either FLAG-MCLT or
silMyoVa, now showing a peak at 200 mm
2. Average NMJ areas
and fibre diameters are given in Table 3. These data strongly
suggest that NMJs shrink upon inhibition of myosin Va in live
adult wildtype mice, and that this diminution is not due to a
decrease in fibre diameter. Furthermore, immunostaining of
presynapses and muscle force recordings upon muscle or nerve
stimulation provide evidence that the transfected muscles were
innervated properly (Fig. S3).
NMJs become fragmented and show a high turnover of
AChRs in muscles transfected with silMyoVa
Next we asked in a kind of pulse-chase experiment, which pool
of AChRs (i.e. either newly synthesised or internalised) is affected
by inhibition of myosin Va. Therefore, TA muscles of adult
Figure 4. Myosin Va tail is enriched in punctate structures in the postsynaptic region of NMJs and co-localises with AChRs and
rapsyn-GFP. TA muscles of adult wildtype mice were co-transfected with rapsyn-GFP and MCST-YFP. Ten days later, transfected muscles were
locally injected with BGT-AF647 and then imaged with in vivo confocal microscopy. Overlay images, BGT-AF647 (red), rapsyn-GFP (green), MCST-YFP
(blue). A: Maximum z-projection of 42 optical slices taken at 2 mm interslice distance encompassing the entire extension of shown NMJs in depth.
Scale bar, 50 mm. B: Single layer through the center of a fibre. Scale bar, 50 mm. C: Binarised blow-up of the boxed region in (B). Overlay, punctate
structures triple positive for BGT-AF647, rapsyn-GFP and MCST-YFP, white arrowheads; double positive for rapsyn-GFP and MCST-YFP, blue
arrowheads. Scale bar, 10 mm.
doi:10.1371/journal.pone.0003871.g004
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co-transfected with rapsyn-GFP and silMyoVa (silMyoVa). During
transfection, BGT-AF647 was injected locally. Ten days later,
transfected muscles were injected with BGT-AF555. Then, BGT-
AF647 and BGT-AF555 fluorescence signals (Fig. 6A, green and
red in overlay images, respectively) were monitored by in vivo
confocal microscopy. Given the extreme stability of the AChR-
BGT complex [41] and the small quantities of BGT (25 pmol)
injected at each occasion, we reasoned that the largest proportion
of BGT should have been available in the circulatory system only
for a limited amount of time and therefore AChRs marked by
BGT should have been surface-exposed at the time point of
injection, i.e. ten days or about one hour before inspection for
BGT-AF647 or BGT-AF555, respectively. Indeed, spectrophoto-
metric measurements suggest that most BGT is available for
binding only during the first few hours upon injection (not shown).
In control muscles, the two BGT fluorescence signals showed a
very nice overlap and clearly depicted the typical arborised
structure of adult NMJs (Fig. 6A, left panels). There was, however,
a gradient of intensities: while BGT-AF647 (referred to as ‘old
receptors’) was preferably localised in the NMJ centre (Fig. 6A,
green in overlay images), BGT-AF555 (referred to as ‘new
receptors’) showed a higher concentration at the rims of NMJs
(Fig. 6A, red in overlay images). Upon co-transfection with
silMyoVa, the overall architecture of NMJs was significantly
altered and appeared fragmented (Fig. 6A, right panels).
Furthermore, although intensity and extension of ‘new receptors’
were still comparable to control muscles (Fig. 6A, compare central
panels), ‘old receptors’ were almost completely gone in silMyoVa
transfected muscles (Fig. 6A, compare upper panels). Finally, as in
the control, in silMyoVa transfected muscles ‘old receptors’ were
found in the centre and ‘new receptors’ at the rim of NMJs.
However, in most cases there was now an almost net separation of
the domains of ‘old receptors’ and ‘new receptors’ (Fig. 6A, bottom
right panel).
Quantitative analyses measuring volume (Fig. 6B) and areas
(Fig. 6C) of fluorescence signals of ‘new receptors’ and ‘old
receptors’ supported these notions. In Fig. 6B those NMJs were
grouped which showed a ratio of ‘old receptor’ to ‘new receptor’
volume signals lower than 0.8 (Fig. 6B, ‘old receptors’%‘new
Figure 5. NMJs shrink upon transfection with FLAG-MCLT or silMyoVa in vivo. TA muscles of adult wildtype mice were co-transfected with
cytoplasmic YFP and FLAG (A–D), FLAG-MCLT (E–H), scrambled silMyoVa (C–D) or silMyoVa (G–H). Ten days later, transfected muscles were locally
injected with BGT-AF647 and imaged with in vivo confocal microscopy. A–B and E–F: Representative maximum z-projections of 74 and 64 optical
slices in A–B and E–F, respectively, taken at 3 mm interslice distance. A and E: Signals of BGT-AF647. Scale bar, 200 mm. B and F: Overlay of BGT-
AF647 (red) and cytoplasmic YFP (green). C–D and G–H: Histograms, fibre diameter distribution (C, G) or NMJ area distribution (D, H) for the same
set of fibres. Scale bars, 10% of total amount of measured fibres or NMJs. For each condition, at least 202 fibres or NMJs from at least 4 different
animals were analysed.
doi:10.1371/journal.pone.0003871.g005
Table 3. Average NMJ areas and fibre diameters upon functional impairment of myosin Va.
FLAG FLAG-MCLT Scrambled silMyoVa silMyoVa
NMJ area (mm
2) 706.8622.7 475.7618.6** 753.4628.2 426.5623.3**
Fibre diameter (mm) 35.160.6 36.860.4 36.260.7 37.460.5
Number of fields (animals) 8 (6) 8 (4) 7 (4) 9 (4)
TA muscles of adult wildtype mice were co-transfected with cytoplasmic YFP and FLAG, FLAG-MCLT, scrambled silMyoVa or silMyoVa, as indicated. Ten days later,
transfected muscles were locally injected with BGT-AF647 and imaged with in vivo confocal microscopy. NMJ areas and diameters of corresponding fibres were
determined. Data, mean6s.e.m.
doi:10.1371/journal.pone.0003871.t003
MyoVa in the Live Mouse NMJ
PLoS ONE | www.plosone.org 8 December 2008 | Volume 3 | Issue 12 | e3871receptors’), between 0.8 and 1.2 (Fig. 6B, ‘old receptors’6‘new
receptors’) or higher than 1.2 (Fig. 6B, ‘old receptors’&‘new
receptors’). It is evident that the signals of ‘old receptors’ exceeded
those of ‘new receptors’ in most NMJs in control conditions
(Fig. 6B, ‘old receptors’&‘new receptors’). Conversely, upon
transfection with silMyoVa, most NMJs showed a smaller volume
of ‘old receptor’ than of ‘new receptor’ signals. When concentrat-
ing on the areas occupied by ‘old receptors’ and ‘new receptors’,
transfection of silMyoVa apparently led in first instance to a strong
reduction in the ‘old receptor’ signals, while ‘new receptor’ signals
remained unaltered (Fig. 6C). In summary, these data indicate that
interference with myosin Va function primarily decreases the
persistence of receptors at the NMJ whereas the delivery of ‘new
receptors’ is less affected.
Rapsyn-GFP is mislocalised and enriched in BGT-positive
punctate structures close to the NMJ in live muscle
transfected with FLAG-MCLT or silMyoVa
The experiments so far have delivered evidence that myosin Va
is localised close to the NMJ, that the interference with the motor
protein’s function induces shrinkage of the NMJ and that this
shrinkage is likely due to a reduced persistence of AChRs at the
NMJ. To better understand the fate of these receptor molecules,
we looked for the enrichment of putative endocytic structures
upon blockage of myosin Va. Therefore, we expressed rapsyn-
GFP, which should be present in both exocytic as well as endocytic
vesicles, together with FLAG or FLAG-MCLT. Ten days after
transfection muscles were locally injected with BGT-AF647. Then,
they were exposed for in vivo microscopy and rapsyn-GFP and
BGT-AF647 fluorescence signals were monitored simultaneously.
As depicted in Fig. 7A, rapsyn-GFP overlapped with the BGT-
stained AChRs in FLAG-transfected muscles (upper panels), but
was largely excluded from the NMJs of most fibres upon
expression of FLAG-MCLT (lower panels). In the latter, rapsyn-
GFP was highly enriched in punctate structures in close proximity
to the NMJ and the amount of rapsyn-GFP positive structures
discontinuous with the NMJ was highly increased (Fig. 7B and C).
To get a hint on the nature of these puncta, we visualised the
BGT-AF647 fluorescence signals in more detail. Given that BGT-
AF647 as a cell-impermeant marker can bind AChRs only upon
their exposure to the cell surface, intracellular BGT-positive
structures should represent endocytic or internalised objects [42].
Remarkably, already one to two hours after BGT injection such
intracellular BGT-positive structures were highly enriched in
FLAG-MCLT co-transfected muscles (Fig. 7B, note filled and
open arrowheads), similar to the situation for rapsyn-GFP.
Furthermore, the extent of co-localisation of rapsyn-GFP with
BGT-AF647 positive structures increased from 45.9%63.0% to
79.9%63.7% (both mean6s.e.m., n=3 animals) in FLAG and
FLAG-MCLT co-transfected muscles, respectively (Fig. 7D).
These in vivo data strongly suggest that myosin Va is important
for the localisation of rapsyn-GFP and that it is likely implicated in
processes concerning internalisation of NMJ components.
Finally, we also addressed the question, from which pool of
AChRs rapsyn-GFP was excluded upon interference with myosin
Va function. Muscles were either transfected with rapsyn-GFP
(control) or co-transfected with rapsyn-GFP and silMyoVa
(silMyoVa) and were simultaneously injected with BGT-AF647.
Ten days later, muscles were injected with BGT-AF555.
Figure 6. Persistence of AChRs in NMJs is reduced in muscles transfected with silMyoVa in vivo. TA muscles of adult wildtype mice were
either transfected with rapsyn-GFP (control) or co-transfected with rapsyn-GFP and silMyoVa (silMyoVa). Simultaneously, muscles were locally injected
with BGT-AF647. Ten days later, transfected muscles were locally injected with BGT-AF555 and then imaged using in vivo confocal microscopy. A:
Maximum z-projections of 13 (control) and 7 (silMyoVa) optical slices taken at 2 mm interslice distance encompassing the entire extensions of shown
NMJs in depth. Overlay image, BGT-AF647 (green), BGT-AF555 (red), co-localisation (yellow). Scale bar, 50 mm. B: Quantification of NMJs exhibiting a
ratio of BGT-AF647 to BGT-AF555 volume signals smaller than 0.8 (‘old receptors’%‘new receptors’), 0.8–1.2 (‘old receptors’6‘new receptors’) or
higher than 1.2 (‘old receptors’&‘new receptors’). Data are from 34 (control) and 61 (silMyoVa) NMJs (4 animals per condition). C: Determination of
BGT-AF647 (‘old receptors’) and BGT-AF555 (‘new receptors’) positive areas in individual NMJs. Data, mean6s.e.m. (control, n=15 NMJs; silMyoVa,
n=24 NMJs, from 2 different animals each).
doi:10.1371/journal.pone.0003871.g006
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PLoS ONE | www.plosone.org 9 December 2008 | Volume 3 | Issue 12 | e3871Figure 7. Amount of rapsyn-GFP positive punctate structures and their co-localisation with BGT-AF647 are increased in FLAG-MCLT
or silMyoVa transfected muscles in vivo. TA muscles of adult wildtype mice were either transfected with rapsyn-GFP (E–F) or co-transfected with
rapsyn-GFP and FLAG (A–D), FLAG-MCLT (A–D) or silMyoVa (E–F). Muscles in E–F were also injected with BGT-AF647 during transfection. Ten days
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receptors’) and rapsyn-GFP signals were monitored with in vivo
confocal microscopy. Fig. 7E depicts 3D projections of 33 and 53
optical slices of control and silMyoVa transfected muscle fibres,
respectively, taken at 1 mm interslice distance (for rotating 3D
views, see Movies S5 and S6). In control muscles rapsyn-GFP, ‘old
receptors’ and ‘new receptors’ appeared co-localised in the NMJ.
The co-localisation was, however, abolished in silMyoVa trans-
fected fibres and, in particular, the ‘old receptors’ and ‘new
receptors’ occupied distinct regions in the postsynapse (Fig. 7E and
F). Furthermore, while in the silMyoVa transfected condition
BGT-AF647 puncta were virtually absent, much more BGT-
AF555 positive puncta were visible than in the control.
Interestingly, most of these BGT-AF555 signals co-localised with
rapsyn-GFP (Fig. 7E–F, lower panels). These results confirmed the
findings of the previous experiments. Further, since BGT-AF555
was injected into the muscle shown in Fig. 7E–F only 90 minutes
prior to image acquisition these data suggested that newly arrived
AChRs and rapsyn-GFP were internalised at a high rate.
Assuming similar internalisation rates of control and myosin Va
inhibited muscles, this could indicate an inefficient recruitment of
endocytosed AChRs in the presence of FLAG-MCLT or
silMyoVa back to the postsynaptic membrane.
Discussion
Depending on strain and physiological status of a muscle,
neuromuscular junctions (NMJs) may undergo significant changes
in size and shape [7,43,44]. In order to maintain the overall
structure of the NMJ intact and yet allow for the necessary
plasticity to occur, an intriguing homeostasis of vesicular exocytic,
endocytic and recycling transport processes is thought to act [21].
We set out to identify the molecular machineries driving these
dynamic processes. Here, we provide in vivo and in vitro evidence
for a crucial role of the molecular motor protein, myosin Va, in the
postsynaptic plasticity of the mammalian nerve-muscle synapse.
First, we show that NMJs in dilute lethal mice (referred to as ‘dilute
mice’ in the following) lacking functional myosin Va exhibit a
postnatal, time-dependent morphological deterioration that cor-
relates with the dramatic aetiopathology leading to lethal seizures
at around P21 (Fig. 1, Fig S1, Movies S1, S2, S3). Initial mild
locomotor symptoms at around P13 coincided with the reduction
of NMJ areas in dilute homozygotes. Seven days later, when
homozygotes showed most severe convulsions, NMJs were in
addition often fragmented. These postsynaptic modifications were
apparently not due to a lack of innervation, since the dilute just as
the control muscles exhibited clear presynaptic terminals and
responded to nerve stimulation with contraction. Given that in
wildtype animals the NMJ size was found to positively correlate
with muscle fibre diameter [44], we also investigated whether fibre
and NMJ sizes correlated with each other. These measurements
revealed that NMJ size reduction preceded diminution of fibre
diameters, indicating that, at least in dilute mice, fibre size
reduction is a secondary effect. This might either be caused by
an altered NMJ activity or by other, unrelated processes. At
present, it is unclear, whether our observation of fragmented and
small NMJs in dilute mice could partially explain their severe
locomotor defects, in particular because previously also a
correlation between aetiopathology and functional defects in the
cerebellum of myosin Va deficient mice and rats was described
[27,45,46], [but see for conflicting results 47,48]. Altogether, our
data on dilute mice suggest a role of myosin Va in postnatal NMJ
maintenance and/or plasticity.
Our experiments using differentiating C2C12 cells (Fig. 2 and
S2) co-transfected with the NMJ marker protein rapsyn-GFP [5]
and a dominant-negative C-terminal fragment of myosin Va
(FLAG-MCLT) showed an accumulation of the NMJ marker in
perinuclear clusters. At present, it is unclear which process resulted
in the increased rapsyn-GFP signal. One might speculate that the
presence of the myosin Va tail fragment either led to an
augmented biosynthesis or to a diminished turnover of the synapse
marker. As to the formation of rapsyn-GFP clusters, these were
reminiscent of vesicle clusters observed in skin melanocytes [32]
and neuroendocrine PC12 cells [35] upon similar treatments,
suggesting a related basic mechanism behind such cluster
formation. Wu et al. proposed a model in which myosin Va acts
through a capture mechanism whereby it retains vesicles travelling
along microtubules in the F-actin-rich cell cortex [32]. Although
the composition of the postsynaptic apparatus of the NMJ exhibits
much more complexity than the C2C12 myotube system it is also
characterised by the presence of nuclei [2] in few micrometers
distance from the membrane as well as submembranous F-actin
[49], which is structured by components of the dystrophin-
associated protein complex and the dystrophin-related protein,
utrophin [49]. Given the particularly well developed F-actin
cytoskeleton underneath the NMJ and the presence of myosin Va
on vesicles positive for AChR and rapsyn-GFP, myosin Va might
play a role in capturing NMJ-related vesicles to facilitate their
incorporation into the postsynaptic membrane, and thereby act in
a similar manner as in skin and neuroendocrine cells.
If myosin Va was important for the trafficking of NMJ
components, it should be present in their vicinity. To address
this issue, we performed biochemical pull-down, in situ immuno-
fluorescence and in vivo microscopy assays (Figs. 3 and 4). A
combination of different biochemical approaches, where either
surface-exposed and internalised (pool 1) or the total AChR
populations (pool 2) were precipitated, showed an enrichment in
tibialis anterior and triceps muscles of myosin Va only in pool 1
but not in pool 2 of AChRs. This result argues for a direct or
indirect association of myosin Va with surface-exposed and/or
internalised AChRs. The presence of endogenous myosin Va at
the NMJ was further substantiated by in situ immunofluorescence
labelling of the motor protein, since this showed up in numerous
punctate structures and aggregates in the close vicinity of the
later, muscles were locally injected with BGT-AF647 (A–D) or BGT-AF555 (E–F) and imaged with in vivo confocal microscopy. A–B: Overlay images,
rapsyn-GFP (green), BGT-AF647 (red), co-localising signals (yellow). Scale bar, 50 mm. A: Maximum z-projections of 80 (FLAG) and 37 (FLAG-MCLT)
optical slices taken at 1.5 and 1 mm interslice distance, respectively, encompassing the entire extensions of shown NMJs in depth. B: Single optical
sections binarised with equal thresholds upon background subtraction for better visibility. Rapsyn-GFP vesicular structures positive and negative for
BGT-AF647 in the overlay image, white-filled and empty arrowheads, respectively. C: Quantification of rapsyn-GFP vesicular structures per
microscopic field ($12 per condition). Data, mean6s.e.m. (n=3 mice). D: Quantification of BGT-AF647 positive and negative rapsyn-GFP vesicular
structures. Data, mean6s.e.m. (n=3 mice, $12 microscopic fields per condition, 1112 (FLAG) and 3982 (FLAG-MCLT) analysed vesicular structures). E–
F: Overlay images, rapsyn-GFP (green), BGT-AF555 (red), BGT-AF647 (blue). Scale bars, 25 mm. E: Maximum z-projections of 33 (control) and 53
(silMyoVa) optical slices taken at 0.8 and 1 mm interslice distance, respectively, encompassing the entire extensions of shown NMJs in depth. F: Single
optical slices binarised with equal thresholds upon background subtraction for better visibility through the centre of shown NMJs. Overlay of rapsyn-
GFP and BGT-AF555 (yellow), of BGT-AF555 and BGT-AF647 (magenta), and of rapsyn-GFP, BGT-AF555 and BGT-AF647 (white).
doi:10.1371/journal.pone.0003871.g007
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marked full length myosin Va and a cargo binding tail fragment of
myosin Va exhibited very similar distributions as endogenous
myosin Va in live mouse muscle. Finally, in vivo co-localisation
studies with co-expressed rapsyn-GFP and endocytosed BGT-
AF647 staining showed a partial overlap of these signals.
Together, these results demonstrate the enrichment in punctate
and cluster-like structures carrying myosin Va in close vicinity to
the NMJ. Further, they strongly suggest that myosin Va interacts
with AChRs, and in fact mainly with those receptors which are
either on the cell surface or internalised, thus according to
literature using endocytic or recycling pathways [21,22].
For a number of in vivo experiments we made use of a muscle-
specific transfection protocol that allows the expression of
heterologous proteins and siRNAs in hind limb muscles of adult
wildtype mice [38–40]. As shown by our previous experiments on
second messenger handling and protein transport in live
contracting mouse muscle [39,50,51], these preparations show
no overt defects in innervation. We have now substantiated this
notion by performing immunohistochemical stainings of neurofil-
ament M and force measurements in muscles transfected with
FLAG-MCLT or silMyoVa (Fig. S3). First, these experiments
showed that each postsynapse exhibited a corresponding presyn-
aptic terminal. Second, we found that the maximal force produced
by silMyoVa transfected hindlimb muscles was very similar to
untransfected control muscles both, when stimulated via the sciatic
nerve as well as through an electrode applied directly on the
muscle. Interestingly, muscle force was slightly (but not signifi-
cantly) weaker in silMyoVa transfected muscles. Together, these
results demonstrate on the one hand that our muscle transfection
protocol per se did not lead to any detectable interference with the
functional integrity of NMJs and muscle; on the other hand, the
morphological changes on NMJs as induced by the functional
impairment of myosin Va may have led to small effects on synaptic
transmission resulting in slightly weaker contractile responses.
Another interesting phenomenon observed during these force
measurements was that fatigue upon muscle electrode stimulation
was reached much faster in control than in silMyoVa transfected
animals. This effect might be explained by a compensatory
mechanism of the muscle fibres to counterbalance the muscle
weakness in the absence of functional myosin Va. Alternatively,
there may exist additional roles of myosin Va within the muscle
fibre which led to an increased fatigue resistance upon impairment
of the motor protein. Such role needs to be analysed in more detail
in future investigations. Using the in vivo transfection approach we
show evidence that blockage of myosin Va function in adult
wildtype mice leads to changes in the morphology of NMJs in a
way that they resemble NMJs in dilute mice (Fig. 5 and Table 3).
Correlative in vivo measurements of fibre diameters allowed ruling
out an indirect effect of the fibre diameter on the NMJ area.
Further information is also provided on the distribution and size
of differentially labeled pools of AChRs (Fig. 6). First, we confirm
earlier findings from ectopic rat NMJs regarding the distribution of
newly and previously added AChRs [52]; i.e. we found that, albeit
in control muscles new and old receptors largely overlapped, BGT
stainings of newly arriving or old receptors showed their highest
densities at the rim or the centre of NMJs, respectively [see also
53]. This suggests that AChRs exhibit considerable lateral mobility
within the NMJ [see also 42] and that the sites of initial addition
and subsequent dwelling of AChRs might differ. Second, in the
case of silMyoVa transfection, fluorescence signals of new and old
receptors were located in largely separate regions. This could
either indicate a distinct mobility of AChRs within the NMJ in the
absence of functional myosin Va or that under this condition at
least a part of the clustered old AChR staining was not within the
postsynaptic membrane but only in close proximity to it.
Our biochemical and fluorescence localisation data suggest, that
myosin Va predominantly interacted with endocytosed or
recycling AChRs (Figs. 3 and 4). If that was the case, one would
expect that impairment of myosin Va function should alter or,
most likely, inhibit such mechanism. Along that line, we reasoned
that inhibition of endocytosis should yield rather larger than
smaller NMJs, thus contradicting our findings. If, however, myosin
Va facilitated recycling of endocytosed AChRs towards the NMJ,
blockage of the motor protein would be expected to diminish NMJ
size; furthermore, if there were multiple rounds of AChR recycling
one would anticipate that the loss of AChRs should aggravate over
time. This expectation was precisely matched in a double-labelling
experiment, in which AChRs were subsequently labeled with two
distinctly coloured BGT species at different time points in the
presence or absence of silMyoVa (Fig. 6). This corroborates earlier
findings of Bruneau and colleagues who suggested an important
role of AChR recycling in the course of NMJ plasticity [21,22].
AChR expression in muscle changes during development:
While embryonic gamma-subunit-containing AChRs are required
for the correct positioning of synaptic contacts during ontogenesis
[54], they are replaced postnatally by adult epsilon-subunit-
containing AChRs. The latter guarantee a constant, high AChR
density and a stable structural organisation of the postsynaptic
apparatus [55]. One aspect of this transition is that AChR
expression becomes stabilised and restricted to subsynaptic regions
while extrajunctional expression is largely reduced [13]. Given
that junctional AChRs in adult muscle undergo periodical
recycling as recently described [21], it is tempting to speculate in
the light of our data that myosin Va mediated AChR recycling is
manifested only after the supply of extrajunctional AChRs
(predominantly gamma-subunit-containing AChRs) has been
depleted. This could explain why impaired recycling of junctional
receptors leads to movement disorders in dilute mice at a relatively
late state, i.e. in the second postnatal week. A scenario in which
adult AChRs get recycled would be similar to the situation for a
number of other cell surface receptors, including the AMPA
receptor in the central nervous system [56,57]. In this context, a
recent work describing the important role of myosin Va in the
recycling of the AMPA receptor during synaptic plasticity of
hippocampal neurons [34] underscores the probability of an
analog function of myosin Va also for the recycling of AChRs at
the NMJ.
In conclusion, we have shown in vitro and in vivo data supporting
a crucial function of myosin Va in muscular postsynaptic plasticity.
Our data are consistent with a model where myosin Va is present
on vesicles containing previously surface-exposed proteinaceous
components of the NMJ, such as AChR, and where inhibition of
the myosin motor leads to a decrease in NMJ size due to a block of
recycling of these components. The correlation we observed
between postnatal aetiopathology and the fragmentation and size
reduction of NMJs in dilute mice lacking functional myosin Va
allows to speculate whether the block of recycling NMJ
components is partially causative for the severe, lethal seizures in
these animals.
Materials and Methods
Expression plasmids and chemicals
Experiments used the following constructs: rapsyn-GFP expres-
sion vector was from Dr. Cohen (Harvard Medical School,
Boston, MA). MCST-YFP and MCST-GFP, expressed in pEYFP-
C1 and pEGFP-C1 (BD Bioscience Clontech), respectively, were
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and brain full length myosin Va-GFP were as described [32,58].
SilMyoVa construct used pSilencer
TM puro 2.1-U6 (Ambion) and
the target sequence: GTTTGCCAGGGTTTGGATC; shuffled
control: GTCGGCTAGCTAATGCATC. Antibodies: anti-neu-
rofilament M (Chemicon), anti-synaptophysin (SySy); anti-
GM130, anti-AChRalpha and anti-calreticulin (BD Bioscience);
anti-myosin Va (LF-18, Sigma), anti-myosin Va (ham5) [32], anti-
beta1-adrenergic receptor (Affinity BioReagents); goat-anti-
mouse-Cy3, goat-anti-mouse-AF488 and goat-anti-rabbit-AF488
(Invitrogen); goat-anti-mouse-HRP (Daco). BGT-biotinXX, BGT-
AF647 and BGT-AF555 (Invitrogen). Draq5 was from Biostatus
Limited. NeutrAvidin Agarose and ECL solution were from
ThermoScientific and Amersham, respectively. All other chemi-
cals were from Sigma, unless stated differently, and of highest
available grade.
Animals and Transfection
C57BL/6J, C57BL/10J mice and DLS/LeJ (P7–21) mice were
used. Animals were from Charles River and then maintained in
the local animal facility. Use and care of animals was as approved
by German authorities and according to national law (TierSchG
117). An intraperitoneal (i.p.) injection of Rompun (Bayer) and
Zoletil 100 (Laboratoires Virbac) was used for anaesthesia.
Transfection was carried out as previously described [38,39].
Myoblast culture and immunostaining
C2C12 mouse myoblasts (ATCC) were cultured in DMEM/
10% FBS (GIBCO) until they reached 70% confluency. Then,
cells were transfected using Lipofectamine2000 (Invitrogen)
according to manufacturer’s instructions and 1 day later the
medium was replaced with DMEM/2% horse serum (GIBCO) for
differentiation. Upon 7 days of differentiation, immunofluores-
cence staining was performed as previously described [35].
Whole mount muscle staining
Muscles were treated as described [54] with collagenase (Typ
1A, Sigma) for 15 minutes and fixed in 1% formaldehyde for
60 minutes. After incubation in 0.1 M glycin over night muscles
were permeabilised in 1% triton/PBS for 8 hours. Primary
antibody was diluted in 2% BSA/PBS and incubated for 1 or 2
nights at 4uC. After washing, secondary antibody and BGT-AF647
were added and incubated over night at 4uC. Imaging was done
after washing in 2% BSA/PBS and PBS.
Cryopreservation, sectioning and staining of muscle
As previously described [54] muscles were extracted, washed
and fixed over night at 4uC in 4% wt/vol paraformaldehyde/PBS,
dehydrated in sucrose solution (10% wt/vol sucrose in distilled
water) for 6 h at 4uC, embedded in tissue freezing medium
(Labonord), frozen in liquid nitrogen and then stored at 280uC.
Longitudinal sections were made at 220uC using a Leica CM1900
cryostat and placed on electrostatic slides (Labonord). Sections
were quenched in 50 mM NH4Cl, permeabilised with 0.1%
TritonX-100, blocked with 10% FBS/PBS and then incubated
with 0.2 pM BGT-AF647/ 0.07 pM BGT-AF555/ 10% FBS/
PBS. Slices were washed and embedded in Mowiol (Calbiochem).
Microscopy
All images were taken with a DMRE TCS SP2 confocal
microscope equipped with Leica Confocal Software 2.61, a KrAr
laser (488 nm, 514 nm), a diode-pumped laser (561 nm), a HeNe
laser (633 nm), a 636/1.4NA HCX PL APO CS oil immersion
objective for fixed samples, a 206/0.7NA HC PL APO CS IMM/
CORR UV or a 636/1.2NA HCX PL APO CS W CORR
objective (immersion medium, Visc-Ophtal gel, Winzer-Pharma)
(all Leica Microsystems) for in vivo observation. Fixed samples:
GFP (excitation 488 nm), Cy3 (excitation 561 nm) and Draq5
signals (excitation 633 nm) of C2C12 cells were acquired using
500–540 nm, 600–630 nm and 650–750 nm bandpass settings,
respectively, in the SP2 unit. 3D image stacks were taken at 8-bit,
and 1024 or 512 pixel resolution with either 16 or 46 zoom,
respectively. BGT-AF647 signals from slices were visualised using
633 nm excitation and emission detection from 650–750 nm.
Images were taken at 512 pixel resolution and 8- and 12-bit for
slices from wildtype and DLS/LeJ mice, respectively. In vivo: 10
days after transfection animals were anaesthetised and transfected
muscles exposed for microscopy. Fibers were imaged up to a depth
of about 400 mm as indicated. Images were taken at 8-bit, 512
pixel resolution, 200 Hz scan frequency, 26 line average. To
determine NMJ areas, 25 pmol of BGT-AF647 and/or BGT-
AF555 were injected intramuscular at least 30 minutes prior to
microscopy. GFP (excitation 488 nm, emission 495–535 nm) and
AF647 signals (excitation 633 nm, emission 660–750 nm) as well
as AF555 (excitation 561 nm, emission 570–620 nm) and AF647
signals (excitation 633 nm, emission 660–750 nm) were imaged
simultaneously. In Fig. 4, YFP (excitation 514 nm, emission 550–
590 nm) was imaged subsequent to simultaneous acquisition of
GFP (excitation 488 nm, emission 490–510 nm) and AF647
(excitation 633 nm, emission 660–750 nm).
Data analysis
Image analysis employed ImageJ program. Analysis of NMJ
size on slices (Fig. 1): Image stacks of BGT-AF647 signals were
median filtered (1 pixel kernel) and thresholded from 50–255 (8-bit
data) or 600–4095 (12-bit data) greyscale values. Then, areas
within these masks were determined for each individual NMJ.
C2C12 cells (Fig. 2): For quantification of rapsyn-GFP signals,
images were binarised (50–255 greyscale threshold) upon back-
ground subtraction. On maximum z-projections, thresholded
signals were counted as GFP-positive areas. Analysis of NMJ
areas and fibre diameters in vivo (Fig. 5): Upon background
subtraction BGT-AF647 signals were median filtered (0.5 pixel
kernel), maximum z-projections made and these then thresholded
from 50–255. For determining the sizes of NMJs, signals in the
threshold masks were measured. For determining fibre diameters,
the largest diameter for each fibre corresponding to analysed
NMJs was determined in the YFP channel. Analysis of NMJ
volumes and areas in vivo (Fig. 6): Upon background
subtraction BGT-AF555 and BGT-AF647 signals were median
filtered (0.5 pixel kernel) and thresholded from 50–255. For
determining the volume of single NMJs, signals in all single images
were measured and cumulated. For determining NMJ areas,
maximum z-projections of binarised 3D stacks were analysed.
Analysis of vesicle co-localisation (Figs. 4 and 7): 3D
image stacks were background-subtracted and median filtered (0.5
pixel kernel). MCST-YFP (Fig. 4) or rapsyn-GFP signals (Fig. 7)
were binarised (20–255 greyscale threshold) and screened for
objects .4 and ,20 pixels
2. Found object outlines were used as
masks in corresponding BGT-AF647 or rapsyn-GFP or MCST-
YFP image stacks. Objects within these masks above background
were counted as co-localising.
AChR pull down and Western blot
Mice were injected i.p. with BGT-biotinXX or left untreated
prior to tissue extraction. Brain and muscle lysates were made
using PreCellys24 homogeniser (PeqLab) with lysis buffer (50 mM
MyoVa in the Live Mouse NMJ
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EDTA, 1 mM EGTA, 2 mM Na3VO4, 1 mM NaF, 0.5 mM
PMSF, 1 mM DTT, 10 mM glycerol phosphate and Complete
Protease Inhibitors (Roche)) and then centrifuged for 10 minutes
at 40006g. Supernatants of lysates from untreated mice were then
incubated with BGT-biotinXX. Subsequently, all supernatants
were incubated with 200 ml NeutrAvidin beads (over night, 4uC),
centrifuged for 1 minute at 5006 g, washed 3 times with lysis
buffer, centrifuged again for 1 minute at 5006 g and eluted by
boiling in Laemmli buffer [59]. After a final centrifugation for
1 minute at 5006 g, aliquots of the supernatant (affinity
precipitates) and of the lysates were subjected to SDS-PAGE
and Western blot analysis as previously described [35]. Western
blot analysis of C2C12 cells was carried out as described [60].
Statistics and graphics
All numeric data were handled using Microscoft Excel 2004 for
Mac, version 11.5. All data shown in graphs represent mean6-
s.e.m. unless otherwise stated. Significance was tested using
student’s t-test, if applicable. Significance levels are indicated in
figures and tables (p#0.05, *; p#0.01, **). For data compilation,
Adobe Photoshop CS2, version 9 and Adobe Illustrator CS2,
version 12.0.0 were employed.
Supporting Information
Figure S1 Active directed movement is increasingly
compromised in DLS/LeJ mice during postnatal devel-
opment as seizures become longer and more intense.
Dilute and healthy littermates were filmed in a standard cage
(16623 cm floorage) at different time points after birth (P9–P20,
indicated). A: Representative trajectories of the unrestrained
animals’ movements during a time period of 5 minutes. Note,
that at P13 and P20 the dilute animal is no more able to actively
follow the healthy littermates. In particular, at P20, the movement
activity of healthy animals is much higher than that of the dilute
sibling. Also, most of the movements still observed for the dilute
mouse were rather due to uncontrolled seizures than to
coordinated movements (see also Movies S2, S3, S4). Scalebar,
5 cm. B: Quantification, mean velocity of all observed animals.
Data, mean6s.e.m. (n=6 and n=3 for healthy and dilute mice,
respectively, from 3 different litters). For each animal and time
point the recording time was ten minutes. Movements were
recorded using the MTrackJ plugin of ImageJ. While healthy
animals show increasingly higher average speed as they grow, dilute
mice do not gain velocity with age. C: Quantification, mean
number of seizures per minute of all observed animals. Seizures
were detected by visual inspection of the original videos taken at
30 frames per second (fps). Data, mean6s.e.m. (P9, n=5; P11,
n=6; P13, n=4; P15, n=5; P17, n=3; P20, n=2. All n-values,
animals). D: Histograms of the duration of seizures in dilute mice as
a function of age. Video data sets as in C. Note, that with
increasing age seizures become longer. At P20, they often extend
over more than a minute and involve the whole body musculature,
while at earlier time points contractures are much shorter and are
mainly restricted to the limb muscles.
Found at: doi:10.1371/journal.pone.0003871.s001 (0.38 MB TIF)
Figure S2 GM130 staining is located around the nuclei of
C2C12 myotubes. C2C12 cells were differentiated for seven
days, fixed and stained with an antibody against the cis-Golgi
marker GM130 and Draq5 to reveal nuclei. Then, confocal
microscopy was performed. Images show fluorescence signals for
GM130, Draq5 or the overlay of both signals, as indicated. In the
overlay images GM130 and Draq5 signals appear red and blue,
respectively. Scale bars, 50 mm. A: Field overview showing a single
optical slice of some polynucleated myotubes and some mononu-
cleated, less differentiated cells. B and C: Blow-up of the lower
right myotube in A. B, single optical slice. C, maximum z-
projection of 10 confocal slices taken at an interslice distance of
1 mm.
Found at: doi:10.1371/journal.pone.0003871.s002 (1.57 MB TIF)
Figure S3 Muscles transfected in vivo with FLAG-MCLT
or silMyoVa are innervated and contract similar to
control muscles. TA (A) or EDL (B–F) muscles of adult
wildtype mice were either transfected with FLAG-MCLT (A) or
silMyoVa (B–F), or left untransfected (control, B and D–F). Ten
days later, muscles were fixed and stained using anti-neurofilament
M antibody and BGT-AF647 (A) or tested with muscle force
measurements (B–F). A: Maximum z-projection of 61 slices taken
at an interslice distance of 1 mm. Overlay image, BGT-AF647
(red), neurofilament M (green), overlay of both signals (yellow).
Scale bar, 50 mm. B–F: Isometric force recordings of EDL
muscles were performed stimulating either the sciatic nerve or the
EDL muscle directly with nerve or muscle electrodes, respectively
(indicated). For the recordings, the anaesthetised animals were
mounted on a custom-made solid support equipped with
micromanipulators to carry electrodes and force transducer.
Custom silver (nerve electrode) and platinum electrodes (muscle
electrode) were used with a Master-8-cp stimulator (A.M.P.I.). The
nerve electrode was inserted next to the sciatic nerve, the muscle
electrode was placed on top of the muscle and both spots were
supplied with physiological solution. Force recordings were
made using an MLT050/A isometric force transducer connect-
ed to a PowerLab 8/30 recorder (both ADInstruments) with a
recording frequency of 2 kHz. Stimulation was performed using
5 ms pulses in trains of 500 ms duration with a frequency of
100 Hz every 4 seconds until half maximal force was reached
(fatigue). Then, recovery from fatigue was verified by single
500 ms trains every minute (recovery). Ba n dC :Representa-
t i v ef o r c et r a c e so fc o n t r o lm u s c l e s( B )o rm u s c l e st r a n s f e c t e d
with silMyoVa (C). The pause between nerve and muscle
stimulation recordings was in each case 10 minutes long. D:
Quantification of the average maximum isometric force
produced by muscles upon nerve or muscle stimulation
(indicated). Data, mean6s.e.m. (n=6 mice). Note, that
maximum forces are similar in all conditions. Force production
u p o nn e r v es t i m u l a t i o ni ns i l M y o V at r a n s f e c t e dm u s c l e si s
slightly, but not significantly, reduced. E: Quantification of the
number of tetani needed to reach 50% of fatigue upon nerve or
muscle stimulation (indicated). Data, mean6s.e.m. (n=6 mice).
F: Relative duration to reach 50% of fatigue upon stimulation of
muscle or nerve. Shown are the averaged quotients of muscle
divided by nerve stimulation values for each tested muscle.
Data, mean6s.e.m. (n=6 mice). Note, that in general fatigue is
reached upon muscle stimulation much slower than upon nerve
stimulation. Interestingly, thi sd i f f e r e n c ei sm u c hm o r ep r o -
nounced in silMyoVa as compared to control animals,
suggesting that these muscles have undergone some adaptive
processes to maintain a certain level of functionality as effect of
the NMJ deteriorating action of silMyoVa transfection.
Found at: doi:10.1371/journal.pone.0003871.s003 (1.22 MB TIF)
Movie S1 Movement of DLS/LeJ mice is normal at P9.
Video of two healthy (black) and one dilute (grey) littermates at P9.
The video has a duration of one minute; it plays in real time
showing 5 fps (original acquisition rate, 30 fps). Cage dimension,
16623 cm. The dilute animal shows no overt seizures and actively
approaches its healthy littermates.
MyoVa in the Live Mouse NMJ
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MOV)
Movie S2 DLS/LeJ mice exhibit seizures and have lost
the ability to follow healthy littermates at P13. Video of
two healthy (black) and one dilute (grey) littermates at P13. The
video has a duration of one minute; it plays in real time showing
5 fps (original acquisition rate, 30 fps). Cage dimension,
16623 cm. The dilute animal shows a number of short periods
of seizures which mainly affect the limb muscles. The animal is no
more able to actively approach its healthy littermates.
Found at: doi:10.1371/journal.pone.0003871.s005 (10.87 MB
MOV)
Movie S3 DLS/LeJ mice exhibit very severe and long-
lasting seizures at P20. Video of two healthy (black) and one
dilute (grey) littermates at P20. The video has a duration of one
minute; it plays in real time showing 5 fps (original acquisition
rate, 30 fps). Cage dimension, 16623 cm. The dilute animal shows
seizures with much prolonged duration, which affect the whole
body musculature, including the dorsal muscles. This leads to
bending and rounding of the body eventually drawing the whole
animal on its back. Then, the intense cramps of the limb muscles
become easily visible.
Found at: doi:10.1371/journal.pone.0003871.s006 (11.52 MB
MOV)
Movie S4 Endogenous myosin Va is localised in punc-
tate structures close to the NMJ. Peronaeus muscle of
wildtype mice (P14) was shortly fixed and stained using ham5 anti-
myosin Va antibody (green) and BGT-AF647 (red) and then
visualised using confocal microscopy. Movie, rotating 3D
projection of 78 optical slices taken at an interslice distance of
500 nm. For better visibility of the different signals, the BGT-
AF647 signal is omitted after each full turn.
Found at: doi:10.1371/journal.pone.0003871.s007 (1.28 MB
MOV)
Movie S5 Upon transfection of rapsyn-GFP NMJs main-
tain their normal shape and rapsyn-GFP, old and new
AChRs perfectly co-localise in vivo. TA muscles of adult
wildtype mice were transfected with rapsyn-GFP (green) and
simultaneously injected with BGT-AF647 (‘old receptors’, blue).
Ten days later, muscles were injected with BGT-AF555 (‘new
receptors’, red). Then, fluorescence signals were monitored with
confocal in vivo microscopy. The movie depicts a rotating 3D
projection of 33 optical slices taken at an interslice distance of
800 nm. For better visibility of the different signals, only the BGT-
AF647 signal shows up initially, then the BGT-AF555 signal is
shown on top after the first full turn and finally the rapsyn-GFP
signal is added, as indicated in the lower left corner of the movie.
The depicted frame has an actual height of 81 mm. Note, that all
three fluorescence signals nicely overlap and exhibit comparable
extensions and intensities. Furthermore, the overall morphology of
the NMJ is richly branched but contiguous.
Found at: doi:10.1371/journal.pone.0003871.s008 (1.68 MB
MOV)
Movie S6 Upon co-transfection of rapsyn-GFP and
silMyoVa NMJs are disrupted and rapsyn-GFP widely
co-localises with new AChRs in intracellular punctate
structures in vivo. TA muscles of adult wildtype mice were co-
transfected with rapsyn-GFP (green) and silMyoVa and simulta-
neously injected with BGT-AF647 (‘old receptors’, blue). Ten days
later, muscles were injected with BGT-AF555 (‘new receptors’,
red). Then, fluorescence signals were monitored with confocal in
vivo microscopy. The movie depicts a rotating 3D projection of 53
optical slices taken at an interslice distance of 1 mm. For better
visibility of the different signals, only the BGT-AF647 signal shows
up initially, then the BGT-AF555 signal is shown on top after the
first full turn and finally the rapsyn-GFP signal is added, as
indicated in the lower left corner of the movie. The depicted frame
has an actual height of 81 mm. Note, that only little ‘old receptors’
remained. These hardly overlap with ‘new receptors’ and rapsyn-
GFP. Conversely, rapsyn-GFP and ‘new receptors’ extensively co-
localise in numerous, intracellular punctate structures and at the
rim of the putative NMJ remainder.
Found at: doi:10.1371/journal.pone.0003871.s009 (2.54 MB
MOV)
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